Hans van Houte, CFO: Nurix Therapeutics NRIX Sell · Filed 23/12/21

Trade details

Type: Insider sale
Amount: $35,410
Shares · price: 3,541 sh · $10.00 a share
Held after: 71,930 sh
Stock: Nurix Therapeutics NRIX
Person: Hans van HouteCFO
Trade date: 23/12/20
Filed: 23/12/21
Days to filing: 1 days

Sold 4.7% of holdings

Share of holding sold: 4.7%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/20~24/01/19

Hans van Houte's recent trades

Hans van HouteCFO
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$110.6K
4,761 sh
$110.6K
Filed 08/04
Traded 08/04
Hans van HouteCFO
Sell10b5-1 planNurix Therapeutics
Sell10b5-1 plan
Nurix Therapeutics
NRIX
$223.4K
13,473 sh
$223.4K
Filed 05/05
Traded 05/05
Hans van HouteCFO
Sell10b5-1 planNurix Therapeutics
Sell10b5-1 plan
Nurix Therapeutics
NRIX
$9,999
582 sh
$9,999
Filed 05/05
Traded 05/05
Hans van HouteCFO
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$238K
14,055 sh
$238K
Filed 05/05
Traded 05/05
Hans van HouteCFO
SellNurix Therapeutics
Sell
Nurix Therapeutics
NRIX
$39.8K
2,388 sh
$39.8K
Filed 04/30
Traded 04/30